Does ALEMTUZUMAB Cause Haemoglobin abnormal? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Haemoglobin abnormal have been filed in association with ALEMTUZUMAB (Campath). This represents 0.1% of all adverse event reports for ALEMTUZUMAB.
17
Reports of Haemoglobin abnormal with ALEMTUZUMAB
0.1%
of all ALEMTUZUMAB reports
0
Deaths
10
Hospitalizations
How Dangerous Is Haemoglobin abnormal From ALEMTUZUMAB?
Of the 17 reports, 10 (58.8%) required hospitalization, and 3 (17.6%) were considered life-threatening.
Is Haemoglobin abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does ALEMTUZUMAB Cause?
Headache (1,808)
Fatigue (1,744)
Pyrexia (1,441)
Off label use (1,259)
Rash (1,094)
Nausea (1,053)
Dyspnoea (855)
Lymphocyte count decreased (852)
Asthenia (841)
Multiple sclerosis relapse (836)
What Other Drugs Cause Haemoglobin abnormal?
RUXOLITINIB (500)
ECULIZUMAB (466)
VENETOCLAX (248)
DARBEPOETIN ALFA (213)
ADALIMUMAB (207)
LENALIDOMIDE (172)
RITUXIMAB (157)
ERYTHROPOIETIN (154)
IBRUTINIB (148)
DEXAMETHASONE (147)
Which ALEMTUZUMAB Alternatives Have Lower Haemoglobin abnormal Risk?
ALEMTUZUMAB vs ALENDRONATE
ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL
ALEMTUZUMAB vs ALENDRONIC ACID
ALEMTUZUMAB vs ALEVE
ALEMTUZUMAB vs ALEVE CAPLET